As Associate Professor, he works mainly with cellular and tissue techniques and animal models using physiopharmacological and biotechnological tools as interface for the analysis of antineoplastic, toxicogenetic and anti-inflammatory mechanisms of prototype molecules or drugs in clinical use with possibility of therapeutic repositioning against chronic disorders with a proliferative and/or inflammatory basis.